MedPath

Nationwide Utilization of Danish Government Electronic Letter System for Confirming the Effectiveness of Behavioral Nudges in Increasing InFLUenza Vaccine Uptake Among Adults with Chronic Disease

Not Applicable
Active, not recruiting
Conditions
Influenza
Behavior and Behavior Mechanisms
Interventions
Behavioral: Behavioral Economic Principles
Registration Number
NCT06600490
Lead Sponsor
Tor Biering-Sørensen
Brief Summary

In randomized clinical trials and observational studies, influenza vaccination has been shown to be effective in reducing influenza-related illness, hospitalizations, cardiovascular events, and mortality in select populations. However, the real-world effectiveness of influenza vaccination is limited by its uptake. Conducted during the 2023/2024 influenza season, the first NUDGE-FLU-CHRONIC trial demonstrated the effectiveness of behavioral nudging letters in increasing influenza vaccination rates among adults aged 18-64 years with chronic diseases in Denmark. This present study will once again investigate whether digital behavioral nudges delivered via the official, mandatory Danish electronic letter system can increase influenza vaccine uptake among adults aged 18-64 years with chronic diseases including whether the effectiveness of the previously successful strategies can be confirmed during a subsequent influenza season.

Detailed Description

The study is a prospective, randomized, open-label implementation trial. The study population will consist of persons aged 18-64 years identified as eligible for free-of-charge influenza vaccination due to a chronic condition. Subjects will be identified through Danish nationwide health registries using codes from the International Classification of Diseases, 10th revision (ICD-10). Individuals will be randomized to 1 of 7 arms (1 usual care arm and 6 intervention arms) with each testing different nudging strategies employing various behavioural economic principles. The interventions will be delivered through the official, mandatory Danish electronic letter system. All subject data will be retrieved from the Danish nationwide registries with the exception of information on intervention allocation. Endpoints will be retrieved at prespecified dates using prespecified search algorithms.

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
308978
Inclusion Criteria
  1. Age 18-64 years

  2. Must be registered in the Danish nationwide registries as meeting at least one of the following eligibility criteria for free-of-charge influenza vaccination in the Danish public health system:

    1. Chronic lung disease
    2. Chronic cardiovascular disease other than hypertension
    3. Type 1 or type 2 diabetes mellitus
    4. Congenital or acquired immunodeficiency
    5. Impaired breathing due to muscular weakness
    6. Chronic renal or hepatic insufficiency
    7. Other chronic conditions with an increased risk of severe influenza as determined by the treating physician
  3. Access to the official, mandatory Danish electronic mailbox system

Exclusion Criteria

None

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Standard LetterBehavioral Economic PrinciplesThis group will receive a standard letter on the benefits of influenza vaccination without behavioral economic enhancement
Repeated LetterBehavioral Economic PrinciplesThe standard letter sent out two times instead of once
Cardiovascular Gain-Framing LetterBehavioral Economic PrinciplesText added to the standard letter highlighting potential cardiovascular benefits of influenza vaccination
Repeated Cardiovascular Gain-Framing LetterBehavioral Economic PrinciplesThe cardiovascular gain-framing letter sent out two times instead of once
Respiratory Gain-Framing LetterBehavioral Economic PrinciplesText added to the standard letter highlighting potential respiratory disease-related benefits of influenza vaccination
Implementation Intention Prompt LetterBehavioral Economic PrinciplesImplementation intention prompt added to the standard letter
Primary Outcome Measures
NameTimeMethod
Number of participants who received an influenza vaccineUp to 3 months
Secondary Outcome Measures
NameTimeMethod
Time from intervention delivery to influenza vaccinationUp to 3 months

Trial Locations

Locations (1)

Center for Translational Cardiology and Pragmatic Randomized Trials, Department of Cardiology, Copenhagen University Hospital - Herlev and Gentofte

🇩🇰

Hellerup, Hovedstaden, Denmark

© Copyright 2025. All Rights Reserved by MedPath